Mirati Therapeutics, Inc. (MRTX)
MRTX moved a median of +0.11% 30 minutes after news, and +0.09% by the close. How MRTX actually reacts to news — the realized, point-in-time move the market made, measured across 109 labeled events over the last three years with zero look-ahead.
MRTX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.07% | 60% | 63 |
| 30-min | +0.11% | 81% | 63 |
| 60-min | +0.11% | 67% | 63 |
| to close | +0.09% | 64% | 63 |
| Middle 50% of MRTX reactions | +0.06% to +0.37% |
|---|---|
| Median reaction (30-min) | +0.11% |
| Measured reactions | 109 |
Half of all Mirati Therapeutics, Inc. news events land between +0.06% and +0.37% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How MRTX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 22 | +0.07% | 77% | +0.36% |
| Coverage initiations | 13 | 0.00% | 46% | -0.18% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how MRTX ranks against every other measured name →
That’s how MRTX usually reacts — get an email when it moves on news →Email me when MRTX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MRTX's baseline. Nothing else.
Recent MRTX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 15-12G Mirati Therapeutics, | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT Mirati Therapeutics, | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form 8-K Mirati Therapeutics, For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM Mirati Therapeutics, | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form POSASR Mirati Therapeutics, | SEC filing · Form POSASR | SEC EDGAR | — | — | |
| Form S-8 POS Mirati Therapeutics, | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation | Press release | PR Newswire | +0.00% | -0.19% | |
| Form 8-K Mirati Therapeutics, For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +0.02% | +0.14% | |
| Form 8-K Mirati Therapeutics, For: Dec 13 | SEC filing · Form 8-K | SEC EDGAR | -0.17% | +0.00% | |
| Form DEFA14A Mirati Therapeutics, | SEC filing · Form DEFA14A | SEC EDGAR | -0.05% | -0.18% | |
| Form DEFA14A Mirati Therapeutics, | SEC filing · Form DEFA14A | SEC EDGAR | +0.47% | +0.19% | |
| Form 8-K Mirati Therapeutics, For: Nov 17 | SEC filing · Form 8-K | SEC EDGAR | -0.16% | -0.26% | |
| Form DEFA14A Mirati Therapeutics, | SEC filing · Form DEFA14A | SEC EDGAR | +0.32% | -0.46% | |
| Form 8-K Mirati Therapeutics, For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | -0.09% | +0.05% | |
| Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure | Press release | PR Newswire | +0.28% | +0.34% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRTX, GAN | Press release | GlobeNewswire | +0.23% | -0.41% | |
| Form 10-Q Mirati Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.02% | +0.14% | |
| Form 8-K Mirati Therapeutics, For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | +0.14% | |
| Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates | Press release | PR Newswire | -0.02% | +0.14% | |
| Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation | Press release | PR Newswire | -0.02% | +0.14% | |
| Form DEFM14A Mirati Therapeutics, | SEC filing · Form DEFM14A | SEC EDGAR | +0.20% | -0.38% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, PCTI, MRTX | Press release | PR Newswire | +0.02% | -0.40% | |
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRTX, ORTX | Press release | Accesswire | +0.14% | +0.69% | |
| Form PREM14A Mirati Therapeutics, For: Oct 23 | SEC filing · Form PREM14A | SEC EDGAR | -0.07% | -0.13% | |
| MRTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Mirati Therapeutics, Inc. to Bristol Myers Squibb | Press release | GlobeNewswire | -0.02% | -0.30% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MRTX section they belong to.
Where else MRTX is measured.
MRTX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aptose Biosciences Inc (APS_TSE) | 110 | 0.00% | 23% |
| DYNATRONICS CORP (DYNT) | 110 | 0.00% | 30% |
| Avinger, Inc. (AVGR) | 108 | -0.24% | 29% |
| Mesoblast Limited - American Depositary Shares (MESO) | 108 | -0.47% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Mirati Therapeutics, Inc.'s median reaction calculated?
Every labeled MRTX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 109 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 81% of MRTX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MRTX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.